EPO Patents = 2

Forward Citations = 7

Loading Chart...

9 inventors (with patents filed for the assignee):

Wang Shen (4 out of 45 patents)

Aimin Zhang (4 out of 6 patents)

Xiaoling Zheng (4 out of 11 patents)

4. Jack Maung (3 out of 18 patents)

5. Zhenzhong Wang (1 out of 19 patents)

6. Wei Xiao (1 out of 21 patents)

7. Qingming Guo (1 out of 1 patent)

8. Yingguang Li (1 out of 1 patent)

9. Junfa Fan (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 11524956 - Alkyne substituted quinazoline compound and methods of use (2022-12-13),

2. 9187459 - Quinazoline-7-ether compounds and methods of use (2015-11-17),

3. 9090588 - Alkyne substituted quinazoline compound and methods of use (2015-07-28),

4. 8987284 - Phosphorus containing quinazoline compounds and methods of use (2015-03-24),

Company Overview

Newgen Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for cancer and other diseases. With a focus on cutting-edge research and innovation, Newgen Therapeutics aims to revolutionize the treatment landscape by delivering advanced and effective treatment options to patients worldwide. Visit their website to learn more about their pipeline of innovative drug candidates and ongoing research efforts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#241 in Menlo Park, CA

#14,051 in California

#60,641 in US

Menlo Park, CA, United States of America

Newgen Therapeutics, Inc.

Forward Citations = 7

9 inventors:

Wang Shen (4 out of 45 patents)

Aimin Zhang (4 out of 6 patents)

Xiaoling Zheng (4 out of 11 patents)

4. Jack Maung (3 out of 18 patents)

5. Zhenzhong Wang (1 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Newgen Therapeutics, Inc.. Retrieved from https://idiyas.com/company/newgen-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]